Fundraising FoxSYLVATICA BIOTECH INC
2 known investors
Find your way into SYLVATICA BIOTECH INC
Sign up to see every warm intro you have to SYLVATICA BIOTECH INC
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SYLVATICA BIOTECH INC team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sylvatica Bio develops organ and tissue preservation technologies, including supercooling methods that extend the viability of human organs such as livers outside the body. Its work targets transplantation, regenerative medicine, and drug discovery within biomedicine.
Investors · 2
Non-dilutive funding · 19 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $2M |
| Department of DefenseDefense Health Program | Phase II | 2021 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $2.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $278.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $248.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $231.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $284K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $219.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $285.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $224.3K |
| U.S. ArmyArmy | Phase I | 2017 | $100K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $275K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $275K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $223.5K |
| Department of DefenseDefense Health Program | Phase I | 2016 | $150K |
| Department of DefenseDefense Health Program | Phase I | 2015 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does SYLVATICA BIOTECH INC do?
- Sylvatica Bio develops organ and tissue preservation technologies, including supercooling methods that extend the viability of human organs such as livers outside the body. Its work targets transplantation, regenerative medicine, and drug discovery within biomedicine.
- Who are SYLVATICA BIOTECH INC's investors?
- SYLVATICA BIOTECH INC's investors include StartX, Taihill Venture.